Biopharmaceutical Company Intercept Relocates Global Headquarters to NJ

On Feb 15, 2022

Intercept Pharmaceuticals, a biopharmaceutical company focusing on the development of drugs to treat chronic liver diseases, has inked a 26,174-square-foot office lease at 305 Madison Ave. in Morristown. The firm will be relocating its global headquarters from 10 Hudson Yards in Manhattan to the 213,857-square-foot office building owned by Crum & Forster^®, a national property casualty insurance group.

“Intercept Pharmaceuticals’ relocation from New York City to Crum & Forster’s world class headquarters in Morristown demonstrates the allure of premier office space and competitive rents that New Jersey has to offer,” said Conor Dolan, who spearheads the leasing campaign at the property and represented Crum & Forster in the lease negotiations. “We are pleased to welcome Intercept Pharmaceuticals into the Crum & Forster building and look forward to welcoming other high-quality tenants as well.”

Completely renovated in 2018, 305 Madison Ave. is situated on 16.2-acres in the heart of Morristown. The three-story office property provides tenants with a variety of amenities including a fitness center, coffee/smoothie bar, auditorium and conference center, outdoor patio and rooftop space, covered parking, and security.

To access more business news, visit NJB News Now.

Related Articles: